HOXA11 and neoplasm: The mice in si-HOXA11-AS#1 or si-HOXA11-AS#2 treatment group showed much lower tumor growth rate, smaller tumor size, and lighter tumor weight, as compared to those of the mice in the si-NC group (Fig. 1G–I).